FDA's Priority Voucher Program Faces Criticism Amid Drug Review Controversies
TL;DR Summary
A new FDA voucher program intended to expedite drug reviews is being used by political officials, including the White House, to influence which medicines are fast-tracked, raising concerns among career scientists about political interference in the drug approval process.
- FDA voucher program has become vehicle for political interference in drug review decisions, staffers say statnews.com
- Exclusive: US FDA taps Merck drugs with blockbuster sales potential for national priority vouchers Reuters
- MSD claims two national priority vouchers; report pharmaphorum
- CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor PharmTech.com
- FDA awards priority vouchers to two investigational drugs By Investing.com Investing.com South Africa
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
1 min
vs 2 min read
Condensed
84%
242 → 39 words
Want the full story? Read the original article
Read on statnews.com